Investor lawyers are again calling for a deep investigation into Royal Philips, warning that a repeat of the company’s apnea-device crisis cannot be ruled out. They allege the Dutch medical technology ...
PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that the company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results